viewHeritage Cannabis Holdings Corp.
The LA company has created a DNA test that uses a saliva sample to identify an individual's genetic variants related to cannabinoid receptors and metabolism
Holdings Corp () signed a letter of intent Wednesday to acquire 30% of Endocanna Health Inc in a $3 million deal.
Los Angeles-based Endocanna has created the Endocannabinoid DNA test that uses a saliva sample to identify an individual's genetic variants related to cannabinoid receptors and metabolism.
That data can then be used to guide users' strain and dosage decisions.
WATCH: Heritage Cannabis finishes large fund raise, purchases facility in Ft Erie, Ontario
As part of the deal, the companies will form a joint venture to represent the EndoDNA technology in Canada. The deal is expected to close by June 28.
"We are excited to be combining our plans for our own Extraction and Medical Sciences divisions with the technology and expertise that Endocanna brings." Chief Science Officer Chris Spooner said. "By utilizing the science-based EndoDNA process, we will be better able to assist patients with selecting and dosing by developing formulations that address the unique pharmacogenomics of individuals."
Heritage is a Canadian cannabis provider focused on becoming a vertically integrated company. It currently owns Voyage Cannabis Corp and CannaCure Corp, two Health Canada-approved cannabis producers.
Contact Andrew Kessel at [email protected]
Follow him on @andrew_kessel
CSE:CANN
Market: CSE
Market Cap: $127.88 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...
on 12/13/2019
2 min read
Prev article
2 min read
